DEF 14A: Surgery Partners Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Sentiment:

Proxy Statement


Surgery Partners, Inc. announces its 2024 annual meeting of stockholders to be held virtually on June 6, 2024, outlining proposals for director elections, executive compensation, and an employee stock purchase plan.

Summary

  • Surgery Partners, Inc. will hold its 2024 annual meeting of stockholders on June 6, 2024, at 2:00 p.m. Central Daylight Time, in a virtual format.
  • Stockholders of record as of April 8, 2024, are entitled to vote at the meeting.
  • The meeting will address the election of four Class III director nominees, an advisory vote on executive compensation, approval of the Employee Stock Purchase Plan (ESPP), and ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • The Board of Directors recommends voting 'FOR' all proposals.
  • The company's Annual Report to Stockholders for the fiscal year ended December 31, 2023, is available online.
  • The notice of internet availability of proxy materials is scheduled to be distributed on or about April 25, 2024.
  • The board is divided into three classes, with Class III directors serving terms expiring at this annual meeting.
  • The company has adopted share ownership and retention guidelines applicable to the NEOs and non-employee directors.

Sentiment

Score: 7

Explanation: The document is a standard corporate communication, presenting information in a neutral and professional tone. The recommendations for voting 'FOR' all proposals suggest a positive outlook from the board's perspective.

Positives

  • The Board of Directors is actively engaged in corporate governance, recommending stockholders vote 'FOR' all proposals.
  • The company is providing an Employee Stock Purchase Plan (ESPP) to incentivize employees, with a maximum of 1,500,000 shares available.
  • The company is making its annual report and proxy materials easily accessible online, promoting transparency.

Future Outlook

The document outlines the proposals to be voted on at the annual meeting, which will shape the company's governance and compensation structure moving forward.

Management Comments

  • Wayne S. DeVeydt, Executive Chairman of the Board of Directors, cordially invites stockholders to attend the 2024 annual meeting.
  • The Board of Directors unanimously recommends that you vote 'FOR' the election of the four Class III director nominees named in the Proxy Statement.
  • The Board of Directors unanimously recommends that you vote 'FOR' the approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.
  • The Board of Directors unanimously recommends that you vote 'FOR' the approval of the ESPP.
  • The Board of Directors unanimously recommends that you vote 'FOR' ratification of the Audit Committees appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm.

Industry Context

This announcement is standard practice for publicly traded companies, ensuring shareholders have a voice in key decisions regarding the company's direction and governance.

Comparison to Industry Standards

  • Holding virtual annual meetings is becoming increasingly common among publicly traded companies, offering greater accessibility for shareholders.
  • The proposals outlined, such as director elections and executive compensation votes, are typical agenda items for annual shareholder meetings.
  • The structure of the Employee Stock Purchase Plan (ESPP) aligns with industry standards, providing employees with an opportunity to purchase company stock at a discounted rate.

Stakeholder Impact

  • Shareholders have the opportunity to influence the company's direction through voting on key proposals.
  • Employees may benefit from the approval of the Employee Stock Purchase Plan (ESPP).
  • The selection of an independent auditor impacts the reliability of financial reporting.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • Stockholders who plan to attend the virtual annual meeting should register in advance, especially if holding shares through an intermediary.
  • The company will announce preliminary voting results at the Annual Meeting and publish results in a Current Report on Form 8-K.

Key Dates

DateDescription
April 8, 2024Record date for stockholders eligible to vote at the annual meeting.
April 25, 2024Scheduled distribution date of the Notice of Internet Availability of Proxy Materials.
June 3, 2024Deadline for intermediaries to submit proof of proxy power for virtual attendance.
June 5, 2024Deadline to receive mailed proxy cards in order to be counted for the Annual Meeting.
June 6, 2024Date of the 2024 annual meeting of stockholders.
December 31, 2024Fiscal year end for which Deloitte & Touche LLP is proposed as the independent registered public accounting firm.
December 26, 2024Deadline for receipt of stockholder proposals for inclusion in next year's proxy statement.
February 6, 2025Earliest date for stockholders to notify the company of proposals for the 2025 annual meeting.
March 8, 2025Latest date for stockholders to notify the company of proposals for the 2025 annual meeting.
April 7, 2025Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees for the 2025 annual meeting.

Keywords

annual meeting, proxy statement, stockholders, directors, executive compensation, employee stock purchase plan, audit firm, corporate governance, Surgery Partners

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.